These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 24099328)

  • 61. Pharmacological Drug Delivery Strategies for Improved Therapeutic Effects: Recent Advances.
    Savaliya R; Singh P; Singh S
    Curr Pharm Des; 2016; 22(11):1506-20. PubMed ID: 26654439
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pharmacokinetic and Pharmacodynamic Features of Nanoemulsion Following Oral, Intravenous, Topical and Nasal Route.
    Choudhury H; Gorain B; Chatterjee B; Mandal UK; Sengupta P; Tekade RK
    Curr Pharm Des; 2017; 23(17):2504-2531. PubMed ID: 27908273
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practice.
    Johnson TN; Rostami-Hodjegan A
    Paediatr Anaesth; 2011 Mar; 21(3):291-301. PubMed ID: 20497354
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nanocarriers in ocular drug delivery: an update review.
    Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
    Curr Pharm Des; 2009; 15(23):2724-50. PubMed ID: 19689343
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Multifunctional DNA Origami Nanoplatforms for Drug Delivery.
    Lu X; Liu J; Wu X; Ding B
    Chem Asian J; 2019 Jul; 14(13):2193-2202. PubMed ID: 31125182
    [TBL] [Abstract][Full Text] [Related]  

  • 66. truPK -- human pharmacokinetic models for quantitative ADME prediction.
    Subramanian K
    Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):555-64. PubMed ID: 16863461
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Breaking the skin barrier: achievements and future directions.
    Zhang H; Zhai Y; Yang X; Zhai G
    Curr Pharm Des; 2015; 21(20):2713-24. PubMed ID: 25925124
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lipid-based drug carriers for prodrugs to enhance drug delivery.
    Zaro JL
    AAPS J; 2015 Jan; 17(1):83-92. PubMed ID: 25269430
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Proniosomes in transdermal drug delivery.
    Rahimpour Y; Kouhsoltani M; Hamishehkar H
    Curr Pharm Des; 2015; 21(20):2883-91. PubMed ID: 25925111
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
    Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Delivery and targeting of nanoparticles into hair follicles.
    Fang CL; Aljuffali IA; Li YC; Fang JY
    Ther Deliv; 2014; 5(9):991-1006. PubMed ID: 25375342
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Patenting of nanopharmaceuticals in drug delivery: no small issue.
    du Toit LC; Pillay V; Choonara YE; Pillay S; Harilall SL
    Recent Pat Drug Deliv Formul; 2007; 1(2):131-42. PubMed ID: 19075880
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Polymeric soft nanocarriers as smart drug delivery systems: State-of-the-art and future perspectives.
    Calderón M; Sosnik A
    Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1277-8. PubMed ID: 26086770
    [No Abstract]   [Full Text] [Related]  

  • 74. Biosensing and drug delivery at the microscale : novel devices for controlled and responsive drug delivery.
    Robitzki AA; Kurz R
    Handb Exp Pharmacol; 2010; (197):87-112. PubMed ID: 20217527
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Disposition of nanoparticle-based delivery system via inner ear administration.
    Chen G; Zhang X; Yang F; Mu L
    Curr Drug Metab; 2010 Dec; 11(10):886-97. PubMed ID: 21208174
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The impact of nanobiotechnology on the development of new drug delivery systems.
    Kayser O; Lemke A; Hernández-Trejo N
    Curr Pharm Biotechnol; 2005 Feb; 6(1):3-5. PubMed ID: 15727551
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmacokinetics and disposition of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) nanoparticles.
    Song X; Zhao X; Zhou Y; Li S; Ma Q
    Curr Drug Metab; 2010 Dec; 11(10):859-69. PubMed ID: 21208172
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pharmacokinetic properties and in silico ADME modeling in drug discovery.
    Honório KM; Moda TL; Andricopulo AD
    Med Chem; 2013 Mar; 9(2):163-76. PubMed ID: 23016542
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Advanced drug delivery nanosystems: perspectives and regulatory issues.
    Demetzos C
    Adv Exp Med Biol; 2015; 822():195-8. PubMed ID: 25416990
    [TBL] [Abstract][Full Text] [Related]  

  • 80. High-throughput in vitro drug release and pharmacokinetic simulation as a tool for drug delivery system development: application to intravitreal ocular administration.
    Sarkhel S; Ramsay E; Kontturi LS; Peltoniemi J; Urtti A
    Int J Pharm; 2014 Dec; 477(1-2):469-75. PubMed ID: 25445526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.